|
Delayed
Bombay S.E.
14:41:23 02/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2,925.00 INR | -2.33% |
|
-3.39% | +18.38% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
ETFs positioned on GlaxoSmithKline Pharmaceuticals Limited
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +11.17% | -.--% | 67 M€ | |
| +21.19% | -.--% | 9,273 M€ | |
| +12.36% | -.--% | 27,154 M€ | |
| -6.98% | -.--% | 2,054 M€ | |
| -.--% | 0.39% | 773 M€ | |
| -17.87% | 0.09% | 108 M€ | |
| +15.76% | 0.08% | 611 M€ | |
| +12.47% | 0.07% | 380 M€ | |
| +12.61% | 0.07% | 337 M€ | |
| -7.85% | 0.07% | 2,692 M€ | |
| -6.15% | 0.07% | 2,189 M€ | |
| -7.38% | 0.05% | 5 M€ | |
| +20.11% | 0.04% | 10 M€ | |
| +15.10% | 0.03% | 223 M€ | |
| -.--% | 0.02% | 7 M€ | |
| +17.48% | 0.02% | 61 M€ | |
| 0.00% | 0.02% | 77 M€ | |
| +16.75% | 0.02% | 199 M€ | |
| +40.01% | 0.02% | 592 M€ | |
| +21.61% | 0.02% | 1,021 M€ | |
| +26.71% | 0.02% | 150 M€ | |
| +21.54% | 0.02% | 268 M€ | |
| -.--% | 0.01% | 11 M€ | |
| +13.25% | 0.01% | 12,827 M€ | |
| +16.80% | 0.01% | 24 M€ | |
| +17.78% | 0.01% | 117 M€ | |
| +21.58% | 0.01% | 216 M€ | |
| +11.45% | 0.01% | 3,667 M€ | |
| +23.13% | 0.01% | 57 M€ | |
| +14.42% | 0.01% | 2,339 M€ | |
| +22.58% | 0.01% | 89 M€ | |
| +13.71% | 0.01% | 535 M€ | |
| +23.57% | 0.01% | 1,808 M€ | |
| +20.14% | 0.01% | 189 M€ | |
| +23.67% | 0.01% | 6,575 M€ | |
| +14.05% | 0.01% | 3,276 M€ | |
| +21.55% | 0.01% | 43,353 M€ | |
| +21.49% | 0.01% | 1,403 M€ |
Employees
3,103
Sector
Pharmaceuticals
- Stock Market
- Stocks
- GLAXO Stock
- ETFs GlaxoSmithKline Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
